245
Views
41
CrossRef citations to date
0
Altmetric
Review

MicroRNA expression in lymphoma

Pages 1363-1374 | Published online: 29 Aug 2007

Bibliography

  • WIGHTMAN B, HA I, RUVKUN G: Posttranscriptional regulation of the heterochronic gene lin-14 by lin-4 mediates temporal pattern formation in C. elegans. Cell (1993) 75(5):855-862.
  • LEE RC, FEINBAUM RL, AMBROS V: The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell (1993) 75(5):843-854.
  • REINHART BJ, SLACK FJ, BASSON M et al.: The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans. Nature (2000) 403(6772):901-906.
  • PASQUINELLI AE, REINHART BJ, SLACK F et al.: Conservation of the sequence and temporal expression of let-7 heterochronic regulatory RNA. Nature (2000) 408(6808):86-89.
  • LEE RC, AMBROS V: An extensive class of small RNAs in Caenorhabditis elegans. Science (2001) 294(5543):862-864.
  • BENTWICH I, AVNIEL A, KAROV Y et al.: Identification of hundreds of conserved and nonconserved human microRNAs. Nat. Genet. (2005) 37(7):766-770.
  • BEREZIKOV E, GURYEV V, VAN DE BELT J et al.: Phylogenetic shadowing and computational identification of human microRNA genes. Cell (2005) 120(1):21-24.
  • LEWIS BP, BURGE CB, BARTEL DP: Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell (2005) 120(1):15-20.
  • JOHN B, ENRIGHT AJ, ARAVIN A et al.: Human MicroRNA targets. PLoS Biol. (2004) 2(11):E363.
  • LEWIS BP, SHIH IH, JONES-RHOADES MW, BARTEL DP, BURGE CB: Prediction of mammalian microRNA targets. Cell (2003) 115(7):787-798.
  • LIM LP, LAU NC, GARRETT-ENGELE P et al.: Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. Nature (2005) 433(7027):769-773.
  • KIM VN: MicroRNA biogenesis: coordinated cropping and dicing. Nat. Rev. Mol. Cell Biol. (2005) 6(5):376-385.
  • LIN SL, CHANG SJ, YING SY: First in vivo evidence of microRNA-induced fragile X mental retardation syndrome. Mol. Psychiatry (2006) 11(7):616-617.
  • RODRIGUEZ A, GRIFFITHS-JONES S, ASHURST JL, BRADLEY A: Identification of mammalian microRNA host genes and transcription units. Genome Res. (2004) 14(10A):1902-1910.
  • BORCHERT GM, LANIER W, DAVIDSON BL: RNA polymerase III transcribes human microRNAs. Nat. Struct. Mol. Biol. (2006) 13(12):1097-1101.
  • ALTUVIA Y, LANDGRAF P, LITHWICK G et al.: Clustering and conservation patterns of human microRNAs. Nucleic Acids Res. (2005) 33(8):2697-2706.
  • HERTEL J, LINDEMEYER M, MISSAL K et al.: The expansion of the metazoan microRNA repertoire. BMC Genomics (2006) 7:25.
  • YEOM KH, LEE Y, HAN J, SUH MR, KIM VN: Characterization of DGCR8/Pasha, the essential cofactor for Drosha in primary miRNA processing. Nucleic Acids Res. (2006) 34(16):4622-4629.
  • ZENG Y: Principles of micro-RNA production and maturation. Oncogene (2006) 25(46):6156-6162.
  • LEE Y, HUR I, PARK SY et al.: The role of PACT in the RNA silencing pathway. EMBO J. (2006) 25(3):522-532.
  • KHVOROVA A, REYNOLDS A, JAYASENA SD: Functional siRNAs and miRNAs exhibit strand bias. Cell (2003) 115(2):209-216.
  • SCHWARZ DS, HUTVAGNER G, DU T et al.: Asymmetry in the assembly of the RNAi enzyme complex. Cell (2003) 115(2):199-208.
  • BAGGA S, BRACHT J, HUNTER S et al.: Regulation by let-7 and lin-4 miRNAs results in target mRNA degradation. Cell (2005) 122(4):553-563.
  • PILLAI RS, BHATTACHARYYA SN, FILIPOWICZ W: Repression of protein synthesis by miRNAs: how many mechanisms? Trends Cell Biol. (2007) 17(3):118-126.
  • CALIN GA, SEVIGNANI C, DUMITRU CD et al.: Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc. Natl. Acad. Sci. USA (2004) 101(9):2999-3004.
  • SEVIGNANI C, CALIN GA, NNADI SC et al.: MicroRNA genes are frequently located near mouse cancer susceptibility loci. Proc. Natl. Acad. Sci. USA (2007) 104(19):8017-8022.
  • CALIN GA, DUMITRU CD, SHIMIZU M et al.: Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc. Natl. Acad. Sci. USA (2002) 99(24):15524-15529.
  • CALIN GA, CROCE CM: MicroRNA-cancer connection: the beginning of a new tale. Cancer Res. (2006) 66(15):7390-7394.
  • LU J, GETZ G, MISKA EA et al.: MicroRNA expression profiles classify human cancers. Nature (2005) 435(7043):834-838.
  • CHEN CZ, LI L, LODISH HF, BARTEL DP: MicroRNAs modulate hematopoietic lineage differentiation. Science (2004) 303(5654):83-86.
  • RAMKISSOON SH, MAINWARING LA, OGASAWARA Y et al.: Hematopoietic-specific microRNA expression in human cells. Leuk. Res. (2005) 30(5):643-647.
  • MONTICELLI S, ANSEL KM, XIAO C et al.: MicroRNA profiling of the murine hematopoietic system. Genome Biol. (2005) 6(8):R71.
  • ZHOU B, WANG S, MAYR C, BARTEL DP, LODISH HF: miR-150, a microRNA expressed in mature B and T cells, blocks early B cell development when expressed prematurely. Proc. Natl. Acad. Sci. USA (2007) 104(17):7080-7085.
  • FAZI F, ROSA A, FATICA A et al.: A minicircuitry comprised of microRNA-223 and transcription factors NFI-A and C/EBPa regulates human granulopoiesis. Cell (2005) 123(5):819-831.
  • GARZON R, PICHIORRI F, PALUMBO T et al.: MicroRNA fingerprints during human megakaryocytopoiesis. Proc. Natl. Acad. Sci. USA (2006) 103(13):5078-5083.
  • FELLI N, FONTANA L, PELOSI E et al.: MicroRNAs 221 and 222 inhibit normal erythropoiesis and erythroleukemic cell growth via kit receptor down-modulation. Proc. Natl. Acad. Sci. USA (2005) 102(50):18081-18086.
  • GEORGANTAS RW III, HILDRETH R, MORISOT S et al.: CD34+ hematopoietic stem-progenitor cell microRNA expression and function: a circuit diagram of differentiation control. Proc. Natl. Acad. Sci. USA (2007) 104(8):2750-2755.
  • RODRIGUEZ A, VIGORITO E, CLARE S et al.: Requirement of bic/microRNA-155 for normal immune function. Science (2007) 316(5824):608-611.
  • THAI TH, CALADO DP, CASOLA S et al.: Regulation of the germinal center response by microRNA-155. Science (2007) 316(5824):604-608.
  • COBB BS, NESTEROVA TB, THOMPSON E et al.: T cell lineage choice and differentiation in the absence of the RNase III enzyme Dicer. J. Exp. Med. (2005) 201(9):1367-1373.
  • MULJO SA, ANSEL KM, KANELLOPOULOU C et al.: Aberrant T cell differentiation in the absence of Dicer. J. Exp. Med. (2005) 202(2):261-269.
  • KANELLOPOULOU C, MULJO SA, KUNG AL et al.: Dicer-deficient mouse embryonic stem cells are defective in differentiation and centromeric silencing. Genes Dev. (2005) 19(4):489-501.
  • BERNSTEIN E, KIM SY, CARMELL MA et al.: Dicer is essential for mouse development. Nat. Genet. (2003) 35(3):215-217.
  • CALIN GA, LIU CG, SEVIGNANI C et al.: MicroRNA profiling reveals distinct signatures in B cell chronic lymphocytic leukemias. Proc. Natl. Acad. Sci. USA (2004) 101(32):11755-11760.
  • CALIN GA, FERRACIN M, CIMMINO A et al.: A microRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. N. Engl. J. Med. (2005) 353(17):1793-1801.
  • CIMMINO A, CALIN GA, FABBRI M et al.: miR-15 and miR-16 induce apoptosis by targeting BCL2. Proc. Natl. Acad. Sci. USA (2005) 102(39):13944-13949.
  • DOHNER H, STILGENBAUER S, BENNER A et al.: Genomic aberrations and survival in chronic lymphocytic leukemia. N. Engl. J. Med. (2000) 343(26):1910-1916.
  • KITADA S, ANDERSEN J, AKAR S et al.: Expression of apoptosis-regulating proteins in chronic lymphocytic leukemia: correlations with in vitro and in vivo chemoresponses. Blood (1998) 91(9):3379-3389.
  • FULCI V, CHIARETTI S, GOLDONI M et al.: Quantitative technologies establish a novel microRNA profile of chronic lymphocytic leukemia. Blood (2007) 109(11):4944-4951.
  • PEKARSKY Y, SANTANAM U, CIMMINO A et al.: Tcl1 expression in chronic lymphocytic leukemia is regulated by miR-29 and miR-181. Cancer Res. (2006) 66(24):11590-11593.
  • DEBERNARDI S, SKOULAKIS S, MOLLOY G et al.: MicroRNA miR-181a correlates with morphological sub-class of acute myeloid leukaemia and the expression of its target genes in global genome-wide analysis. Leukemia (2007) 21(5):912-916.
  • GARZON R, PICHIORRI F, PALUMBO T et al.: MicroRNA gene expression during retinoic acid-induced differentiation of human acute promyelocytic leukemia. Oncogene (2007) 26(28):4148-4157.
  • GAUWERKY CE, HUEBNER K, ISOBE M, NOWELL PC, CROCE CM: Activation of MYC in a masked t(8;17) translocation results in an aggressive B-cell leukemia. Proc. Natl. Acad. Sci. USA (1989) 86(22):8867-8871.
  • SONOKI T, IWANAGA E, MITSUYA H, ASOU N: Insertion of microRNA-125b-1, a human homologue of lin-4, into a rearranged immunoglobulin heavy chain gene locus in a patient with precursor B-cell acute lymphoblastic leukemia. Leukemia (2005) 19(11):2009-2010.
  • SEER: Cancer statistics review, 1975 – 2002. National Cancer Institute (2005).
  • LUM AM, WANG BB, LI L et al.: Retroviral activation of the mir-106a microRNA cistron in T lymphoma. Retrovirology (2007) 4:5.
  • WANG CL, WANG BB, BARTHA G et al.: Activation of an oncogenic microRNA cistron by provirus integration. Proc. Natl. Acad. Sci. USA (2006) 103(49):18680-18684.
  • YAO Y, ZHAO Y, XU H et al.: Marek's disease virus type 2 (MDV-2)-encoded microRNAs show no sequence conservation to those encoded by MDV-1. J. Virol. (2007) 81(13):7164-7170.
  • BURNSIDE J, BERNBERG E, ANDERSON A et al.: Marek's disease virus encodes MicroRNAs that map to meq and the latency-associated transcript. J. Virol. (2006) 80(17):8778-8786.
  • COIFFIER B: Diffuse large cell lymphoma. Curr. Opin. Oncol. (2001) 13(5):325-334.
  • ALIZADEH AA, EISEN MB, DAVIS RE et al.: Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature (2000) 403(6769):503-511.
  • HANS CP, WEISENBURGER DD, GREINER TC et al.: Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood (2004) 103(1):275-282.
  • LAWRIE CH, SONEJI S, MARAFIOTI T et al.: MicroRNA expression distinguishes between germinal center B cell-like (GCB) and activated B cell-like (ABC) subtypes of diffuse large B cell lymphoma. Int. J. Cancer (2007) 121(5):1156-1161.
  • TAM W, BEN-YEHUDA D, HAYWARD WS: Bic, a novel gene activated by proviral insertions in avian leukosis virus-induced lymphomas, is likely to function through its noncoding RNA. Mol. Cell. Biol. (1997) 17(3):1490-1502.
  • CLURMAN BE, HAYWARD WS: Multiple proto-oncogene activations in avian leukosis virus-induced lymphomas: evidence for stage-specific events. Mol. Cell. Biol. (1989) 9(6):2657-2664.
  • METZLER M, WILDA M, BUSCH K, VIEHMANN S, BORKHARDT A: High expression of precursor microRNA-155/BIC RNA in children with Burkitt lymphoma. Genes Chromosomes Cancer (2004) 39(2):167-169.
  • EIS PS, TAM W, SUN L et al.: Accumulation of miR-155 and BIC RNA in human B cell lymphomas. Proc. Natl. Acad. Sci. USA (2005) 102(10):3627-3632.
  • DAVIS RE, BROWN KD, SIEBENLIST U, STAUDT LM: Constitutive NF-κB activity is required for survival of activated B cell-like diffuse large B cell lymphoma cells. J. Exp. Med. (2001) 194(12):1861-1874.
  • PEDERSEN LM, JURGENSEN GW, JOHNSEN HE: Serum levels of inflammatory cytokines at diagnosis correlate to the bcl-6 and CD10 defined germinal centre (GC) phenotype and bcl-2 expression in patients with diffuse large B-cell lymphoma. Br. J. Haematol. (2005) 128(6):813-819.
  • KLUIVER J, HARALAMBIEVA E, DE JONG D et al.: Lack of BIC and microRNA miR-155 expression in primary cases of Burkitt lymphoma. Genes Chromosomes Cancer (2006) 45(2):147-153.
  • KLUIVER J, POPPEMA S, DE JONG D et al.: BIC and miR-155 are highly expressed in Hodgkin, primary mediastinal and diffuse large B cell lymphomas. J. Pathol. (2005) 207(2):243-249.
  • VAN DEN BERG A, KROESEN BJ, KOOISTRA K et al.: High expression of B-cell receptor inducible gene BIC in all subtypes of Hodgkin lymphoma. Genes Chromosomes Cancer (2003) 37(1):20-28.
  • JIANG J, LEE EJ, SCHMITTGEN TD: Increased expression of microRNA-155 in Epstein–Barr virus transformed lymphoblastoid cell lines. Genes Chromosomes Cancer (2006) 45(1):103-106.
  • COSTINEAN S, ZANESI N, PEKARSKY Y et al.: Pre-B cell proliferation and lymphoblastic leukemia/high-grade lymphoma in E(μ)-miR155 transgenic mice. Proc. Natl. Acad. Sci. USA (2006) 103(18):7024-7029.
  • HE L, THOMSON JM, HEMANN MT et al.: A microRNA polycistron as a potential human oncogene. Nature (2005) 435(7043):828-833.
  • RINALDI A, PORETTI G, KWEE I et al.: Concomitant MYC and microRNA cluster miR-17-92 (C13orf25) amplification in human mantle cell lymphoma. Leuk. Lymphoma (2007) 48(2):410-412.
  • VOLINIA S, CALIN GA, LIU CG et al.: A microRNA expression signature of human solid tumors defines cancer gene targets. Proc. Natl. Acad. Sci. USA (2006) 103(7):2257-2261.
  • HAYASHITA Y, OSADA H, TATEMATSU Y et al.: A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation. Cancer Res. (2005) 65(21):9628-9632.
  • O';DONNELL KA, WENTZEL EA, ZELLER KI, DANG CV, MENDELL JT: c-Myc-regulated microRNAs modulate E2F1 expression. Nature (2005) 435(7043):839-843.
  • WOODS K, THOMSON JM, HAMMOND SM: Direct regulation of an oncogenic micro-RNA cluster by E2F transcription factors. J. Biol. Chem. (2007) 282(4):2130-2134.
  • KREK A, GRUN D, POY MN et al.: Combinatorial microRNA target predictions. Nat. Genet. (2005) 37(5):495-500.
  • GRIFFITHS-JONES S, GROCOCK RJ, VAN DONGEN S, BATEMAN A, ENRIGHT AJ: miRBase: microRNA sequences, targets and gene nomenclature. Nucleic Acids Res. (2006) 34(Database issue):D140-D144.
  • GAUR A, JEWELL DA, LIANG Y et al.: Characterization of microRNA expression levels and their biological correlates in human cancer cell lines. Cancer Res. (2007) 67(6):2456-2468.
  • KARUBE Y, TANAKA H, OSADA H et al.: Reduced expression of Dicer associated with poor prognosis in lung cancer patients. Cancer Sci. (2005) 96(2):111-115.
  • KUMAR MS, LU J, MERCER KL, GOLUB TR, JACKS T: Impaired microRNA processing enhances cellular transformation and tumorigenesis. Nat. Genet. (2007) 39(5):673-677.
  • HAMMOND SM: MicroRNAs as tumor suppressors. Nat. Genet. (2007) 39(5):582-583.
  • BLOOMSTON M, FRANKEL WL, PETROCCA F et al.: MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis. JAMA (2007) 297(17):1901-1908.
  • LEE EJ, GUSEV Y, JIANG J et al.: Expression profiling identifies microRNA signature in pancreatic cancer. Int. J. Cancer (2007) 120(5):1046-1054.
  • SZAFRANSKA AE, DAVISON TS, JOHN J et al.: MicroRNA expression alterations are linked to tumorigenesis and non-neoplastic processes in pancreatic ductal adenocarcinoma. Oncogene (2007) 26(30):4442-4452.
  • ROLDO C, MISSIAGLIA E, HAGAN JP et al.: MicroRNA expression abnormalities in pancreatic endocrine and acinar tumors are associated with distinctive pathologic features and clinical behavior. J. Clin. Oncol. (2006) 24(29):4677-4684.
  • TAKAMIZAWA J, KONISHI H, YANAGISAWA K et al.: Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival. Cancer Res. (2004) 64(11):3753-3756.
  • MATTIE MD, BENZ CC, BOWERS J et al.: Optimized high-throughput microRNA expression profiling provides novel biomarker assessment of clinical prostate and breast cancer biopsies. Mol. Cancer (2006) 5:24.
  • IORIO MV, FERRACIN M, LIU CG et al.: MicroRNA gene expression deregulation in human breast cancer. Cancer Res. (2005) 65(16):7065-7070.
  • HAMMOND SM: MicroRNA therapeutics: a new niche for antisense nucleic acids. Trends Mol. Med. (2006) 12(3):99-101.
  • KRUTZFELDT J, RAJEWSKY N, BRAICH R et al.: Silencing of microRNAs in vivo with ‘antagomirs’. Nature (2005) 438(7068):685-689.
  • BARTLING B, HOFMANN HS, BOETTGER T et al.: Comparative application of antibody and gene array for expression profiling in human squamous cell lung carcinoma. Lung Cancer (2005) 49(2):145-154.
  • VARAMBALLY S, YU J, LAXMAN B et al.: Integrative genomic and proteomic analysis of prostate cancer reveals signatures of metastatic progression. Cancer Cell (2005) 8(5):393-406.
  • MATTICK JS: Non-coding RNAs: the architects of eukaryotic complexity. EMBO Rep. (2001) 2(11):986-991.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.